Characterization of the Low Molecular Weight Human Serum Proteome*S
By R. Tirumalai, King C. Chan, DaRue Prieto, H. Issaq, Thomas P. Conrads, Timothy D. Veenstra. Molecular & Cellular Proteomics, 2003
792 citations recorded by the source corpus.
Serum potentially carries an archive of important histological information whose determination could serve to improve early disease detection. The analysis of serum, however, is analytically challenging due to the high dynamic concentration range of constituent protein/peptide species, necessitating extensive fractionation prior to mass spectrometric analyses. The low molecular weight (LMW) serum proteome is that protein/peptide fraction from which high molecular weight proteins, such as albumin, immunoglobulins, transferrin, and lipoproteins, have been removed. This LMW fraction is made up of several classes of physiologically important proteins such as cytokines, chemokines, peptide hormones, as well as proteolytic fragments of larger proteins. Centrifugal ultrafiltration of serum was used to remove the large constituent proteins resulting in the enrichment of the LMW proteins/peptides. Because albumin is known to bind and transport small molecules and peptides within the circulatory system, the centrifugal ultrafiltration was conducted under solvent conditions effecting the disruption of protein-protein interactions. The LMW serum proteome sample was digested with trypsin, fractionated by strong cation exchange chromatography, and analyzed by microcapillary reversed-phase liquid chromatography coupled on-line with electrospray ionization tandem mass spectrometry. Analysis of the tandem mass spectra resulted in the identification of over 340 human serum proteins; however, not a single peptide from serum albumin was observed. The large number of proteins identified demonstrates the efficacy of this method for the removal of large abundant proteins and the enrichment of the LMW serum proteome.
Subfields: Molecular Biology, Spectroscopy
View Paper: https://www.semanticscholar.org/paper/12512526f00e7818f8e1e3b006c0b2bb5ccc6809
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- B. Aslam
- M. Khurshid
- M. Basit
- Eleftherios P. Diamandis
- M. Rasool
- M. A. Nisar
- C. Alix‐Panabières
- K. Pantel
In Spectroscopy
- B. Aslam
- M. Khurshid
- M. Basit
- Eleftherios P. Diamandis
- M. Rasool
- M. A. Nisar
- C. Alix‐Panabières
- K. Pantel
Citations in the corpus
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologies (2008, methodology): “The low-molecular-weight serum proteome has been characterized by ultrafiltration, enzymatic digestion, and liquid chromatography coupled to tandem mass spectrometr”
- Proteomics: Technologies and Their Applications. (2017, background): “The serum consists of various chemokines, cytokines, peptide hormones and proteolytic fragments of large proteins that can be purified using strong cation exchange chromatography (33).”